{"schema_version":"secwatch.filing_event.v1","accession":"0001613103-24-000162","form_type":"8-K","ticker":"MDT","cik":"0001613103","company_name":"Medtronic plc","filed_at":"2024-11-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.984299+00:00","generated_at":"2026-05-29T22:30:01.813275+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Medtronic Q2 revenue $8.4B (+5.3%); raises FY25 organic growth and EPS guidance","bullets":["GAAP diluted EPS $0.99 (up 46% YoY); non-GAAP diluted EPS $1.26 (up 1% as reported, 8% constant currency).","Revenue $8.403B, organic growth 5.0%; driven by TAVR, PFA, leadless pacemakers, Diabetes, Spine, Neuromodulation.","FY25 organic revenue growth guidance raised to 4.75%-5% from 4.5%-5%; non-GAAP EPS guidance raised to $5.44-$5.50 from $5.42-$5.50.","Diabetes revenue $686M (+12.4% as reported, +11% organic) on continued adoption of MiniMed 780G AID system.","Cardiovascular portfolio revenue $3.102B (+6.1% as reported, +5.6% organic) with high-single digit growth in Structural Heart (Evolut FX+ TAVR launch)."],"urls":{"canonical":"https://secwatch.observer/filing/0001613103-24-000162","json":"https://secwatch.observer/filing/0001613103-24-000162.json","markdown":"https://secwatch.observer/filing/0001613103-24-000162.md","text":"https://secwatch.observer/filing/0001613103-24-000162.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1613103/000161310324000162/0001613103-24-000162-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1613103/000161310324000162/mdt-20241119.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T22:30:01.813275+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}